Results 171 to 180 of about 137,068 (205)
Some of the next articles are maybe not open access.
Best Practice & Research Clinical Gastroenterology, 2002
Steatohepatitis in children occurs in the childhood version of non-alcoholic fatty liver disease (NAFLD), as a result of hepatotoxicity and with certain genetic/metabolic diseases. Until recently, NAFLD was considered to be rare in children. It is now recognized as an important childhood liver disease, especially because childhood obesity is much more ...
openaire +2 more sources
Steatohepatitis in children occurs in the childhood version of non-alcoholic fatty liver disease (NAFLD), as a result of hepatotoxicity and with certain genetic/metabolic diseases. Until recently, NAFLD was considered to be rare in children. It is now recognized as an important childhood liver disease, especially because childhood obesity is much more ...
openaire +2 more sources
Seminars in Liver Disease, 2002
In addition to the usual associations with insulin resistance, type 2 diabetes, central obesity, and hypertriglyceridemia, nonalcoholic steatohepatitis (NASH) has been associated with several drugs and toxins. However, drug-induced liver disease is a relatively uncommon cause of steatohepatitis.
openaire +2 more sources
In addition to the usual associations with insulin resistance, type 2 diabetes, central obesity, and hypertriglyceridemia, nonalcoholic steatohepatitis (NASH) has been associated with several drugs and toxins. However, drug-induced liver disease is a relatively uncommon cause of steatohepatitis.
openaire +2 more sources
Non-alcoholic Steatohepatitis in Children
Clinics in Liver Disease, 2003Non-alcoholic steatohepatitis (NASH) is an important liver disease in children; it can cause cirrhosis in children. The disease mechanism involves hepatic insulin resistance with hyperinsulinemia and changes in certain adipocytokines and inflammatory mediators.
openaire +3 more sources
Therapeutic pipeline in nonalcoholic steatohepatitis
Nature Reviews Gastroenterology and Hepatology, 2021Raj Vuppalanchi +2 more
exaly
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Nature Reviews Gastroenterology and Hepatology, 2023Josep M Llovet +2 more
exaly
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
New England Journal of Medicine, 2021Philip N Newsome +2 more
exaly
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
Nature Reviews Gastroenterology and Hepatology, 2020sven Francque +2 more
exaly